| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/08/1998 | CA2259316A1 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
| 01/08/1998 | CA2255893A1 Prenyl transferase inhibitors |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816360A1 Benzothiophene compounds, intermediates, processes, and methods of use |
| 01/07/1998 | EP0816357A1 Substituted indazole derivatives |
| 01/07/1998 | EP0815255A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/07/1998 | EP0814821A1 Immunomodulating compositions from bile for the treatment of immune system disorders |
| 01/07/1998 | EP0814803A2 Use of anti-oestrogens as male contraceptives |
| 01/07/1998 | EP0814800A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 01/07/1998 | EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 01/07/1998 | EP0814785A1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility |
| 01/07/1998 | EP0814775A1 Method and kit for preventing erectile dysfunction |
| 01/07/1998 | CN1169308A Prepatatory Chinese medicine for treatment of prostate hyperplasia, prostatitis and urinary stone |
| 01/07/1998 | CN1036918C Novel benzopyran derivatives and activating agent containing same |
| 01/06/1998 | US5705658 Azido containing tetrahydro furan compounds |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705507 Aplha-substituted-3-benzyl-benzofurans |
| 01/02/1998 | CA2206752A1 Benzothiophene compounds, intermediates, processes, and methods of use |
| 12/31/1997 | WO1997049707A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 12/31/1997 | WO1997049680A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997049394A2 Sold oral dosage forms of valsartan |
| 12/31/1997 | WO1997049286A1 Il-8 receptor antagonists |
| 12/31/1997 | CN1168794A Method of reducing tissue damage associated with non-cardiac ischemia |
| 12/31/1997 | CN1036836C Method for preparing medicine for transcortical application contg. steroidhormonen |
| 12/31/1997 | CA2258885A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | CA2258850A1 Il-8 receptor antagonists |
| 12/30/1997 | US5703113 Benzopyran derivatives |
| 12/30/1997 | US5703112 Method of preventing emesis using tetrahydrobenz CD!indole-6-carbonxamides |
| 12/30/1997 | US5703109 Cyanophenyl-1,2,4-triazole derivative |
| 12/30/1997 | US5703106 Treating various cardiovascular, urogenital, brain disorders |
| 12/30/1997 | US5703077 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 12/30/1997 | US5703066 Treating gynecological disorders |
| 12/29/1997 | EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics |
| 12/29/1997 | EP0813875A2 Inhibition of abnormal accumulation of extracellular matrices |
| 12/29/1997 | EP0813871A1 Berberine derivates for inhibiting production of HSP47 |
| 12/29/1997 | EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 12/29/1997 | EP0813417A1 Use of hyaluronic acid for the treatment of interstitial cystitis |
| 12/29/1997 | EP0731711B1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents |
| 12/24/1997 | WO1997048682A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 12/24/1997 | WO1997048400A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | WO1997048399A1 Certain phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | WO1997048379A1 Nasal administration of desmopressin |
| 12/24/1997 | WO1997040006A3 Phosphate mimics |
| 12/24/1997 | CN1168376A Process for preparing sildenafil |
| 12/24/1997 | CA2258589A1 Certain phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | CA2258587A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | CA2258552A1 Nasal administration of desmopressin |
| 12/24/1997 | CA2258536A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 12/23/1997 | US5700911 Bone morphogenetic protein -11 (BMP-11) compositions |
| 12/23/1997 | US5700807 Endothelin receptor antagonists |
| 12/23/1997 | US5700798 Methods for using benzoxazines for treating asthma |
| 12/23/1997 | CA2126972C Styrene derivative and salts thereof |
| 12/19/1997 | CA2208136A1 Inhibition of abnormal accumulation of extracellular matrices |
| 12/18/1997 | WO1997047298A1 Therapeutic treatment for cardiovascular diseases |
| 12/18/1997 | WO1997031895A3 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 12/18/1997 | CA2257693A1 Therapeutic treatment for cardiovascular diseases |
| 12/17/1997 | EP0812845A1 Process for preparing sildenafil |
| 12/17/1997 | EP0812831A1 Benzimidazole derivatives and their use as corticotropin releasing factor antagonists |
| 12/17/1997 | EP0812319A1 2-arylbenzazole compounds |
| 12/17/1997 | EP0812196A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 12/17/1997 | CN1168137A Pyridazinones as endothelin-receptor antagonists |
| 12/17/1997 | CN1167617A Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 12/16/1997 | US5698589 Water-based topical cream containing nitroglycerin and method of preparation and use thereof |
| 12/16/1997 | US5698581 Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them |
| 12/16/1997 | US5698572 Methods of inhibiting turner's syndrome |
| 12/16/1997 | US5698554 Preventing and treating nephritis, endotoxic shock |
| 12/16/1997 | US5698552 Hetrazepinoid amides |
| 12/16/1997 | US5698516 Biologically active vasopressin analogues |
| 12/16/1997 | US5698230 Nutrition |
| 12/11/1997 | WO1997046579A1 Neuropeptide y agonists |
| 12/11/1997 | WO1997046522A1 Novel vitamin d analogues |
| 12/11/1997 | CA2257424A1 Neuropeptide y agonists |
| 12/10/1997 | EP0811684A2 Oxytocin receptor portion or variant, and dna coding for the same |
| 12/10/1997 | EP0811621A2 Carbamoyl substituted oxazoles as thromboxane receptor antagonists |
| 12/10/1997 | EP0811008A1 Bicyclic benzazepine derivatives as vasopressin antagonists |
| 12/10/1997 | EP0811001A1 Benzothiazine dioxides as endothelin antagonists |
| 12/10/1997 | EP0810874A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 12/10/1997 | EP0810864A1 2,6-diaryl pyridazinones with immunosuppressant activity |
| 12/10/1997 | EP0641302B1 Alcohols as potassium channel openers and in treatment of urinary incontinence |
| 12/10/1997 | CN1036651C Method for prepn. of carbostyril derivatives |
| 12/09/1997 | US5696172 Containing complexing agent, preservative and ph adjuster to maintain ph between 7.5 and 8.5 for oxidation resistance and storage stability |
| 12/09/1997 | US5696146 3-((2,2-disubstituted-1,3-benzodioxolan-5-yl)methylcarbonyl) indole derivatives; useful for treating acne vulgaris, alpecia, seborrhoea, female hirsutism, benign prostatic hypertrophy and male pattern baldness |
| 12/09/1997 | US5696145 Vasopressin and oxytocin receptor |
| 12/09/1997 | US5696138 Urea derivatives and their use |
| 12/09/1997 | US5696112 Fused heterocyclic azepines as vasopressin antagonists |
| 12/09/1997 | US5696107 Administering androsten-3-ol |
| 12/09/1997 | US5695770 Induction of cytotoxic T-lymphocyte responses |
| 12/09/1997 | US5695760 Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation |
| 12/04/1997 | WO1997045417A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification |
| 12/04/1997 | WO1997045105A1 Compositions and methods for treating or preventing diseases of body passageways |
| 12/04/1997 | CA2227811A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification |
| 12/03/1997 | EP0809701A1 Calcineurin regulatable adenylate cyclase |
| 12/03/1997 | EP0809700A1 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 12/03/1997 | EP0809660A1 Polymeric compounds |
| 12/03/1997 | EP0809636A1 Substituted isoxazoles for the treatment of inflammation |
| 12/03/1997 | EP0809517A1 Anti-transforming growth factor-beta gene therapy |
| 12/03/1997 | EP0746343A4 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE -i(IN VIVO) OR -i(EX VIVO) |